Neoadjuvant chemotherapy use in bladder cancer: A survey of current practice and opinions

Advances in Urology

Volumn , Issue , 2014, Pages

  Cowan, N G ^a   Chen, Y ^b   Downs, T M ^c   Bochner, B H ^d   Apolo, A B ^e   Porter, M P ^f   La Rochelle, J C ^a   Amling, C L ^a   Koppie, T M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902142582     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2014/746298     Document Type: Article

References (21)

1. November 2012, http://www.cancer.gov/cancertopics/types/bladder
2. November 2012, http://www.cancer.org/cancer/bladdercancer/detailedguide/ bladder-cancer-survival-rates
3. Grossman H. B., Natale R. B., Tangen C. M., Speights V. O., Vogelzang N. J., Trump D. L., DeVere White R. W., Sarosdy M. F., Wood D. P. Jr., Raghavan D., Crawford E. D., Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. The New England Journal of Medicine 2003 349 9 859 866 2-s2.0-0041429507 10.1056/NEJMoa022148 (Pubitemid 37025405)
4. Vale C. L., Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data. European Urology 2005 48 2 202 205 2-s2.0-21844450899 10.1016/j.eururo.2005.04.006 (Pubitemid 40957088)
5. Griffiths G., International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. Journal of Clinical Oncology 2011 29 16 2171 2177 2-s2.0-79957960529 10.1200/JCO.2010.32.3139
6. Stenzl A., Cowan N. C., De Santis M., Treatment of muscle-invasive and metastatic bladder cancer: update of EAU guidelines. European Urology 2011 59 1009 1018
7. David K. A., Milowsky M. I., Ritchey J., Carroll P. R., Nanus D. M., Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. Journal of Urology 2007 178 2 451 454 2-s2.0-34447095141 10.1016/j.juro.2007.03.101 (Pubitemid 47030482)
8. Raj G. V., Karavadia S., Schlomer B., Arriaga Y., Lotan Y., Sagalowsky A., Frenkel E., Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. Cancer 2011 117 2 276 282 2-s2.0-78650972192 10.1002/cncr.25429
9. Meeks J. J., Bellmunt J., Bochner B. H., Clarke N. W., Daneshmand S., Galsky M. D., Hahn N. M., Lerner S. P., Mason M., Powles T., Sternberg C. N., Sonpavde G., A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. European Urology 2012 62 3 523 533 2-s2.0-84864423349 10.1016/j.eururo.2012.05.048
10. Burger M., Mulders P., Witjes W., Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. European Urology 2012 61 5 1070 1071 2-s2.0-84859419726 10.1016/j.eururo.2012.01.039
11. Fedeli U., Fedewa S. A., Ward E. M., Treatment of muscle invasive bladder cancer: evidence from the national cancer database, 2003 to 2007. Journal of Urology 2011 185 1 72 78 2-s2.0-78650026897 10.1016/j.juro.2010.09.015
12. Herr H. W., Dotan Z., Donat S. M., Bajorin D. F., Defining optimal therapy for muscle invasive bladder cancer. Journal of Urology 2007 177 2 437 443 2-s2.0-33846168443 10.1016/j.juro.2006.09.027 (Pubitemid 46075130)
13. Niegisch G., Lorch A., Droller M. J., Lavery H. J., Stensland K. D., Albers P., Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit? European Urology 2013 64 3 355 357 2-s2.0-84881158258 10.1016/j.eururo.2013.06.002
14. Donat S. M., Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality. Journal of the National Comprehensive Cancer Network 2009 7 1 40 43 2-s2.0-58149339885
15. International Collaboration of Trialists, Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. The Lancet 1999 354 533 540
16. Lee C. T., Madii R., Daignault S., Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. Journal of Urology 2006 175 1262 1267
17. Chang S. S., Hassan J. M., Cookson M. S., Wells N., Smith J. A. Jr., Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. Journal of Urology 2003 170 4, part 1 1085 1087 2-s2.0-0042693021 10.1097/01.ju.0000086828.26001.ca (Pubitemid 37108084)
18. Alva A. S., Tallman C. T., He C., Hussain M. H., Hafez K., Montie J. E., Smith D. C., Weizer A. Z., Wood D., Lee C. T., Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach. Cancer 2012 118 1 44 53 2-s2.0-83855162922 10.1002/cncr.26240
19. Sternberg C. N., Bellmunt J., Sonpavde G., Siefker-Radtke A. O., Stadler W. M., Bajorin D. F., Dreicer R., George D. J., Milowsky M. I., Theodorescu D., Vaughn D. J., Galsky M. D., Soloway M. S., Quinn D. I., ICUD-EAU international consultation on bladder cancer 2012: chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings. European Urology 2013 63 1 58 66 2-s2.0-84870571565 10.1016/j.eururo.2012.08.010
20. Dash A., Galsky M. D., Vickers A. J., Serio A. M., Koppie T. M., Dalbagni G., Bochner B. H., Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. Cancer 2006 107 3 506 513 2-s2.0-33746298622 10.1002/cncr.22031 (Pubitemid 44107210)
21. Eldefrawy A., Soloway M. S., Katkoori D., Singal R., Pan D., Manoharan M., Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: the likelihood of initiation and completion. Indian Journal of Urology 2012 28 4 424 426 2-s2.0-84873444321 10.4103/0970-1591.105756